Bitcoin

Crypto markets are currently under a macro‑driven fear phase (Fear & Greed 26). Any credible breakthrough in high‑cost, high‑impact sectors like gene therapy can slightly soften risk aversion, especially as institutional investors watch biotech as a proxy for future biotech‑linked crypto projects (e.g., health‑data tokens). This event also underscores the growing narrative of cutting‑edge science intersecting with decentralized finance, a theme gaining traction on Twitter and niche forums.

A 6‑year‑old girl regained sight after receiving Luxturna gene therapy at Great Ormond Street Hospital.